General Discussion Thread, page-336

First 336 Last

Share
Profile

Follow
Salubrious

6,641 Posts.

1625

04/08/19

21:47

Post #: 39853240
Share

Originally posted by Hunterr: ↑

Some announcements should come out within the next 2 weeks maybe even as soon as this week.

1: July revenue

2: debt facility (and already in use)

And who knows what else TED has for us.

Also guys I don’t know if this is allowed to be done or not,

So would like some feedback from you holders and see what’s your thoughts.

I was thinking once EN1 starts being profitable and making a decent chunk of change,

Can EN1 buy shares with some of the revenue on market?

Just say EN1 makes 25 mill can EN1 put aside 3 mill to buy shares on market?

That will give less shares out there for retail holders because EN1 would be the holder of them. ?

(And clean up the weak hands)

And let’s say they accumulate 3 mill worth for 10c then once the SP is at 20c and they want some extra cash they can sell to an institution for 6 mill and double the money for the company.?

Or even just keep them shares and lessen the dilution.

( although there is not a great deal of shares on the market compared to others I held)

I know they can use that 3 mill to by slots and therefore make money on the 3 mill I get that.

But I thought it could be a good idea to use some money to buy shares.

If it could be done and they do end up buying back some shares once dividends are a possibility then that’s money again for EN1.?

Like to hear what you guys think if it could be done or not. ?

Expand

no mate, a share buyback should be the last thing on Ted's mind. that's what businesses with excess cash and nowhere to spend it might do, if it makes more sense than a dividend.
more likely a CR than a buyback. we need the cash, still growing. you should know this dropping $100k+ on it!

EN1 Price at posting: 3.6¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HAS

Hastings progressing Yangibana to production with lower costs

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia